Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5972)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2021 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yamada K, Sawada T, Nakamura M, Yamamura T, Maeda K, Ishikawa E, Iida T, Mizutani Y, Kakushima N, Ishikawa T, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Furune S, Hase T, Yokota K, Maeda O, Hashimoto N, Akiyama M, Ando Y, Fujishiro M. Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival. World J Gastroenterol 2021; 27(41): 7190-7206 [PMID: 34887637 DOI: 10.3748/wjg.v27.i41.7190] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i41/7190.htm |
| Number | Citing Articles |
| 1 |
Shusu Liu, Peiyu Lu, Bixia Yang, Yan Yang, Hua Zhou, Min Yang. Single-cell RNA sequencing analysis of peripheral blood mononuclear cells in PD-1-induced renal toxicity in patients with lung cancer. BMC Nephrology 2024; 25(1) doi: 10.1186/s12882-024-03754-0
|
| 2 |
Guihong Wan, Wenxin Chen, Sara Khattab, Katie Roster, Nga Nguyen, Boshen Yan, Ahmad Rajeh, Jayhyun Seo, Hannah Rashdan, Leyre Zubiri, Matthew J Hadfield, Shadmehr Demehri, Kun-Hsing Yu, William Lotter, Alexander Gusev, Nicole R LeBoeuf, Kerry L Reynolds, Shawn G Kwatra, Yevgeniy R Semenov. Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study. The Lancet Oncology 2024; 25(8): 1053 doi: 10.1016/S1470-2045(24)00278-X
|
| 3 |
Longcong Dong, Ruibin Zhang, Qin Huang, Yuan Shen, Hongying Li, Shuguang Yu, Qiaofeng Wu. Construction, bioinformatics analysis, and validation of competitive endogenous RNA networks in ulcerative colitis. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.951243
|
| 4 |
Kristian C. Williams, Abigail Gault, Amy E. Anderson, Christopher J. Stewart, Christopher A. Lamb, R. Ally Speight, Neil Rajan, Ruth Plummer, Arthur G. Pratt. Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerations. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1122430
|
| 5 |
Li Na Feng, Jin He, Li Xia Feng, Yan Li, Juan Li, Chen Chen. Symptoms, symptom clusters and associated factors among cancer patients receiving immune checkpoint inhibitor therapy: A cross-sectional survey. European Journal of Oncology Nursing 2023; 63: 102288 doi: 10.1016/j.ejon.2023.102288
|
| 6 |
Qinan Yin, Liuyun Wu, Lizhu Han, Xingyue Zheng, Rongsheng Tong, Lian Li, Lan Bai, Yuan Bian. Immune-related adverse events of immune checkpoint inhibitors: a review. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1167975
|
| 7 |
Jing Lin, Zhong-Qiao Lin, Shi-Cheng Zheng, Yu Chen. Immune checkpoint inhibitor-associated gastritis: Patterns and management. World Journal of Gastroenterology 2024; 30(14): 1941-1948 doi: 10.3748/wjg.v30.i14.1941
|
| 8 |
Mina Hosseini, Nima Rezaei. Lung Cancer Diagnosis and Treatment: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 9: 103 doi: 10.1007/16833_2022_52
|
| 9 |
Qian Sun, Hongyan Sun, Nan Wu, Yue Hu, Fangqing Zhang, Xianling Cong. Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.976224
|
| 10 |
Sae Ohwada, Keisuke Ishigami, Noriyuki Akutsu, Hiroshi Nakase. Pharmacological Treatments Available for Immune-Checkpoint-Inhibitor-Induced Colitis. Biomedicines 2022; 10(6): 1334 doi: 10.3390/biomedicines10061334
|
| 11 |
Jing Wang, Ziyue Guo, Mengyi Shen, Qi Xie, Hongjie Xiang. Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1366489
|
| 12 |
Noelia Silva-Pilipich, Ángela Covo-Vergara, Cristian Smerdou. Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors. Cancers 2023; 15(8): 2352 doi: 10.3390/cancers15082352
|
| 13 |
Taito Fukushima, Satoshi Kobayashi, Makoto Ueno. The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors. Japanese Journal of Clinical Oncology 2024; 54(9): 949 doi: 10.1093/jjco/hyae067
|